Results 111 to 120 of about 12,561 (235)

The GLP‐1 Receptor Agonist Paradox in Dermatology: Why We Cannot Afford the Knowledge Gap

International Journal of Dermatology, Volume 65, Issue 7, Page 1361-1362, July 2026.
Ramy Awadalla, Derek Davies
wiley   +1 more source

A Case for Anti‐IgE Vaccination

Allergy, Volume 81, Issue 6, Page 2001-2013, June 2026.
ABSTRACT Immunoglobulin E (IgE) plays a central role in allergic diseases by binding to the high‐affinity receptor FcεRI on mast cells and basophils, where allergen‐induced crosslinking triggers potent inflammatory responses. Various mechanisms by which IgE responses are generated and functionally regulated remain elusive despite many years of research.
Paul Engeroff, Zahra Gharailoo, Monique Vogel, Martin F. Bachmann   +3 more
wiley   +1 more source

Bullous Pemphigoid Associated with Captopril

, 1989
Captopril is commonly prescribed to patients with hypertension and congestive heart failure. Adverse dermatological reactions have been reported in about ten percent of patients receiving captopril.
James W. Cooper, Louise Mallet, Joyce Thomas   +2 more
core   +1 more source

Brunsting-Perry Pemphigoid of the Scalp with Antibodies against Laminin 332 [PDF]

, 2011
S. Zgažarová, Zgazarova, S., A. Niedermeier, M. Hertl, Hertl, M., H. Jedlickova, Jedlickova, H., Niedermeier, A.   +7 more
core   +1 more source

Bullous pemphigoid complicating human orf disease [PDF]

, 2018
Orf is a zoonosis caused by Parapoxvirus and transmitted to human by sheep. Bullous pemphigoid has been reported as an occasional complication following orf. We report a 51-year-old female who developed bullous pemphigoid 3 weeks following orf.
Ogretmen, Zerrin, Akalın, Taner, Gül, Ceren, Ekinci, Alper   +3 more
core   +1 more source

Exploring Pruritus in Bullous Pemphigoid: Analysis of QOL Metrics and Potential Biological Mechanisms

JID Innovations
Bullous pemphigoid is a devastating autoimmune blistering disease with need for improved therapeutics. Limited data are available on the overall burden of pruritus and alterations over time; however, treatment of itch-specific pathways may provide novel ...
Olive C. Osuoji, Taryn DeGrazia, Robin Rolader, Emily F. Cole, Katy Lawson, Henry Hilley, Yanyan Xing, Liang Han, Sarah Chisolm, Henry Claussen, Xiaobo Yan, Yuxian Sun, Yuan Liu, Suephy C. Chen, Ron J. Feldman   +14 more
doaj   +1 more source

Skin Fragility and Hyperpigmentation in a Patient With HIV

JEADV Clinical Practice, Volume 5, Issue 2, Page 716-718, June 2026.
Catalina Retamal, Maximiliano Maass, María Fernanda Martin   +2 more
wiley   +1 more source

Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran

Acta Medica Iranica, 2018
Bullous Pemphigoid is a chronic immunobullous disease, characterized by subepidermal bulla on the skin and mucosa. The purpose of the present study was to investigate the clinicoepidemiological features of bullous pemphigoid in Iranian patients.
Kamran Balighi, Maryam Daneshpazhooh, Hamidreza Mahmoudi, Maryam Nasimi, Alireza Delavari, Arghavan Azizpour   +5 more
doaj  

Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib

JEADV Clinical Practice
Both bullous pemphigoid and mucous membrane pemphigoid are autoimmune bullous diseases that can be challenging to treat in individual cases. Janus kinase inhibitors have shown efficacy in several autoimmune and inflammatory diseases, although these drugs
Tamás Malkovics, Orsolya N. Horváth, Miklós Sárdy   +2 more
doaj   +1 more source

Childhood bullous pemphigoid. a clinical case report and literature review.

, 2022
Bullous pemphigoid is an autoimmune subepidermal bullous skin disease that causes pruritic urticarial or eczematous lesions and tense blisters filled with clear fluid or blood.
Petruškevičiūtė, Evelina,
core